ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
17 hedge funds and large institutions have $2.13M invested in Acorda Therapeutics, Inc. in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 0 closing their positions.
Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$15K |
| 2 |
2
BlackRock
New York
|
$80.7K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$1.4K |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$49.4K |
